The results are from the first seven participants who received a single administration of investigational SPK-9001 at a dose of ...
In addition to SPK-9001, Spark Therapeutics previously received breakthrough therapy designation for voretigene neparvovec, which is being developed for the potential treatment of inherited retinal ...
777Funds , a Nigeria-based decentralized finance (DeFi) startup, today reported continued product and market progress as it nears mainnet deployment...
Read moreDetails
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.
